Please login to the form below

systemic lupus erythematosus

This page shows the latest systemic lupus erythematosus news and features for those working in and with pharma, biotech and healthcare.

Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi

Ablynx also has vobarilizumab for systemic lupus erythematosus in phase II, with results due in the first half of the year that will trigger an option decision by AbbVie.

Latest news

GSK closes in on EU approval for triple COPD therapy

Benlysta is used as an add-on treatment for adults with active, autoantibody-positive systemic lupus erythematosus (SLE).
Celgene pays $300m upfront for immunology start-up Delinia

The drug has potential in a variety of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, says Celgene, which also claims rights to related second-generation candidates.
Merck's pharma unit faces tougher 2017 as fertility boost recedes

Meanwhile, Merck suffered a setback in its mid-stage pipeline recently after its systemic lupus erythematosus (SLE) candidate atacicept failed to meet its objectives in a clinical trial, although it did
GSK and AZ drugs impress in lupus trials

GSK and AZ drugs impress in lupus trials. Raises hope for better treatment for debilitating disease. ... Two antibody-based drugs from GlaxoSmithKline and AstraZeneca have shown promise efficacy in systemic lupus erythematosus (SLE), raising the hope of
Pfizer launches lupus study with 23andMe

The companies, which will also work with the Lupus Research Institute, aim to enroll 5, 000 individuals with systemic lupus erythematosus, with patient recruitment expected to be completed by mid-2016. ... The study forms the first concrete output from

More from news
Approximately 2 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Pharma deals during September 2012

In a similar vein, Biogen Idec has sold its royalty rights to Benlysta (belimunab) for the treatment of systemic lupus erythematosus, to DRI Capital Managed Fund. ... Royalty monetisation. Benlysta (belimunab) for the treatment of systemic lupus

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Santhera CEO Klaus Schollmeier joins SuppreMol

This product is SM101, which is being investigated for its use in the treatment of primary immune thrombocytopenia (ITP) and systemic lupus erythematosus (SLE).

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Random42 Scientific Communication

Creativity International Awards - Systemic Lupus Erythematosus . 2016 - Silver. Creativity International Awards - Normal Hemostasis and von Willebrand Factor (VWF). ... 2016 - Bronze. The Telly Awards - Systemic Lupus Erythematosus. 2016 - Bronze.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Manager / Account Director: Great salary and bebefits

Senior Account Manager – Med Comms – Kent: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Editor – Medical Education Agency – Bucks: Salary TBC

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Project Manager, Medical Communications, London: Excellent Salary

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Editorial Director – Medical Education – Oxford: Negotiable

Senior Account Manager or AD - Medical Communications: Salary TBC

Account Manager – Med Comms – London: Salary TBC

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Medical Writer, e-learning/ training, London: Excellent Salary

Senior Medical Writer: Great salary and benefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Senior Medical Writer: Great salary and bebefits

Scientific Director: Great salary and bebefits

Subscribe to our email news alerts

PMHub

Add my company

Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...